A股異動 | 南嶺民爆(002096.SZ)復牌一字漲停 擬收購易普力100%股份 確立國內民爆行業龍頭地位
格隆匯11月3日丨南嶺民爆(002096.SZ)復牌一字漲停,報11.63元,股價創近11個月新高,總市值43億元。南嶺民爆昨晚披露發行股份購買資產並募集配套資金暨關聯交易預案,公司擬向葛洲壩、攀鋼集團以及93名自然人發行股份購買易普力全部股權,進而實現中國能建分拆易普力重組上市。重組後的南嶺民爆有望成為民爆行業新的龍頭。公吿顯示,目前最終交易價格及發行股份數量均尚未確定。此外,南嶺民爆還擬以詢價方式非公開發行股份募集配套資金。易普力是一家集民爆物品生產、銷售、爆破和礦山開採服務於一體的專業化公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.